John R. Clark

A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer

Nathan A. Pennell, Gilbert H. Daniels, Robert I. Haddad et al. · Thyroid · 2007 · 198 citations

Medicine, Oncology, Pharmacology +12

Tritrophic phenological match–mismatch in space and time

Malcolm D. Burgess, Ken W. Smith, Karl L. Evans et al. · Nature Ecology & Evolution · 2018 · 157 citations · Full text

Life Sciences, Biology, Ecology +5

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

Arnon I. Dreyfuss, John R. Clark, Barbara G. Fallon et al. · Cancer · 1987 · 154 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma

William A. Michaud, Anthony C. Nichols, Edmund A. Mroz et al. · Clinical Cancer Research · 2009 · 151 citations · Full text

Medicine, Cancer Biology, Oncology +17

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of<i>ERBB2</i>rather than<i>EGFR</i>

Ezra E.W. Cohen, Mark W. Lingen, Leslie E. Martin et al. · Clinical Cancer Research · 2005 · 129 citations

Medicine, Oncology, Pharmacology +15